EyePoint Pharmaceuticals (EYPT) EPS (Basic): 2010-2018
Historic EPS (Basic) for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Sep 2018 value amounting to -$0.44.
- EyePoint Pharmaceuticals' EPS (Basic) fell 193.33% to -$0.44 in Q3 2018 from the same period last year, while for Sep 2018 it was -$1.34, marking a year-over-year decrease of 179.40%. This contributed to the annual value of -$1.15 for FY2018, which is 121.15% down from last year.
- Latest data reveals that EyePoint Pharmaceuticals reported EPS (Basic) of -$0.44 as of Q3 2018, which was up 29.03% from -$0.62 recorded in Q2 2018.
- EyePoint Pharmaceuticals' 5-year EPS (Basic) high stood at $0.70 for Q3 2014, and its period low was -$0.62 during Q2 2018.
- Its 3-year average for EPS (Basic) is -$0.22, with a median of -$0.15 in 2018.
- Its EPS (Basic) has fluctuated over the past 5 years, first surged by 600.00% in 2014, then plummeted by 563.14% in 2017.
- EyePoint Pharmaceuticals' EPS (Basic) (Quarterly) stood at -$0.14 in 2014, then declined by 28.57% to -$0.18 in 2015, then surged by 89.11% to -$0.02 in 2016, then plummeted by 563.14% to -$0.13 in 2017, then tumbled by 193.33% to -$0.44 in 2018.
- Its last three reported values are -$0.44 in Q3 2018, -$0.62 for Q2 2018, and -$0.15 during Q1 2018.